report cover

OTC Anti-Infective Medicine Market, Global Outlook and Forecast 2025-2032

  • 23 July 2025
  • Life Sciences
  • 100 Pages
  • Report code : 24WT-8053021

OTC Anti-Infective Medicine and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 OTC Anti-Infective Medicine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global OTC Anti-Infective Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global OTC Anti-Infective Medicine Overall Market Size
2.1 Global OTC Anti-Infective Medicine Market Size: 2024 VS 2032
2.2 Global OTC Anti-Infective Medicine Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top OTC Anti-Infective Medicine Players in Global Market
3.2 Top Global OTC Anti-Infective Medicine Companies Ranked by Revenue
3.3 Global OTC Anti-Infective Medicine Revenue by Companies
3.4 Top 3 and Top 5 OTC Anti-Infective Medicine Companies in Global Market, by Revenue in 2024
3.5 Global Companies OTC Anti-Infective Medicine Product Type
3.6 Tier 1, Tier 2, and Tier 3 OTC Anti-Infective Medicine Players in Global Market
3.6.1 List of Global Tier 1 OTC Anti-Infective Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 OTC Anti-Infective Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global OTC Anti-Infective Medicine Market Size Markets, 2024 & 2032
4.1.2 Antibacterials Medicine
4.1.3 Antivirals Medicine
4.1.4 Antifungals Medicine
4.1.5 Antiparasitic Medicine
4.2 Segmentation by Type - Global OTC Anti-Infective Medicine Revenue & Forecasts
4.2.1 Segmentation by Type - Global OTC Anti-Infective Medicine Revenue, 2020-2025
4.2.2 Segmentation by Type - Global OTC Anti-Infective Medicine Revenue, 2026-2032
4.2.3 Segmentation by Type - Global OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global OTC Anti-Infective Medicine Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.2 Segmentation by Application - Global OTC Anti-Infective Medicine Revenue & Forecasts
5.2.1 Segmentation by Application - Global OTC Anti-Infective Medicine Revenue, 2020-2025
5.2.2 Segmentation by Application - Global OTC Anti-Infective Medicine Revenue, 2026-2032
5.2.3 Segmentation by Application - Global OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global OTC Anti-Infective Medicine Market Size, 2024 & 2032
6.2 By Region - Global OTC Anti-Infective Medicine Revenue & Forecasts
6.2.1 By Region - Global OTC Anti-Infective Medicine Revenue, 2020-2025
6.2.2 By Region - Global OTC Anti-Infective Medicine Revenue, 2026-2032
6.2.3 By Region - Global OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America OTC Anti-Infective Medicine Revenue, 2020-2032
6.3.2 United States OTC Anti-Infective Medicine Market Size, 2020-2032
6.3.3 Canada OTC Anti-Infective Medicine Market Size, 2020-2032
6.3.4 Mexico OTC Anti-Infective Medicine Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe OTC Anti-Infective Medicine Revenue, 2020-2032
6.4.2 Germany OTC Anti-Infective Medicine Market Size, 2020-2032
6.4.3 France OTC Anti-Infective Medicine Market Size, 2020-2032
6.4.4 U.K. OTC Anti-Infective Medicine Market Size, 2020-2032
6.4.5 Italy OTC Anti-Infective Medicine Market Size, 2020-2032
6.4.6 Russia OTC Anti-Infective Medicine Market Size, 2020-2032
6.4.7 Nordic Countries OTC Anti-Infective Medicine Market Size, 2020-2032
6.4.8 Benelux OTC Anti-Infective Medicine Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia OTC Anti-Infective Medicine Revenue, 2020-2032
6.5.2 China OTC Anti-Infective Medicine Market Size, 2020-2032
6.5.3 Japan OTC Anti-Infective Medicine Market Size, 2020-2032
6.5.4 South Korea OTC Anti-Infective Medicine Market Size, 2020-2032
6.5.5 Southeast Asia OTC Anti-Infective Medicine Market Size, 2020-2032
6.5.6 India OTC Anti-Infective Medicine Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America OTC Anti-Infective Medicine Revenue, 2020-2032
6.6.2 Brazil OTC Anti-Infective Medicine Market Size, 2020-2032
6.6.3 Argentina OTC Anti-Infective Medicine Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa OTC Anti-Infective Medicine Revenue, 2020-2032
6.7.2 Turkey OTC Anti-Infective Medicine Market Size, 2020-2032
6.7.3 Israel OTC Anti-Infective Medicine Market Size, 2020-2032
6.7.4 Saudi Arabia OTC Anti-Infective Medicine Market Size, 2020-2032
6.7.5 UAE OTC Anti-Infective Medicine Market Size, 2020-2032
7 Companies Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Corporate Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline OTC Anti-Infective Medicine Major Product Offerings
7.1.4 GlaxoSmithKline OTC Anti-Infective Medicine Revenue in Global Market (2020-2025)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck OTC Anti-Infective Medicine Major Product Offerings
7.2.4 Merck OTC Anti-Infective Medicine Revenue in Global Market (2020-2025)
7.2.5 Merck Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer OTC Anti-Infective Medicine Major Product Offerings
7.3.4 Pfizer OTC Anti-Infective Medicine Revenue in Global Market (2020-2025)
7.3.5 Pfizer Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis OTC Anti-Infective Medicine Major Product Offerings
7.4.4 Novartis OTC Anti-Infective Medicine Revenue in Global Market (2020-2025)
7.4.5 Novartis Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Corporate Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott OTC Anti-Infective Medicine Major Product Offerings
7.5.4 Abbott OTC Anti-Infective Medicine Revenue in Global Market (2020-2025)
7.5.5 Abbott Key News & Latest Developments
7.6 Sanofi
7.6.1 Sanofi Corporate Summary
7.6.2 Sanofi Business Overview
7.6.3 Sanofi OTC Anti-Infective Medicine Major Product Offerings
7.6.4 Sanofi OTC Anti-Infective Medicine Revenue in Global Market (2020-2025)
7.6.5 Sanofi Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb OTC Anti-Infective Medicine Major Product Offerings
7.7.4 Bristol-Myers Squibb OTC Anti-Infective Medicine Revenue in Global Market (2020-2025)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche OTC Anti-Infective Medicine Major Product Offerings
7.8.4 Roche OTC Anti-Infective Medicine Revenue in Global Market (2020-2025)
7.8.5 Roche Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. OTC Anti-Infective Medicine Market Opportunities & Trends in Global Market
Table 2. OTC Anti-Infective Medicine Market Drivers in Global Market
Table 3. OTC Anti-Infective Medicine Market Restraints in Global Market
Table 4. Key Players of OTC Anti-Infective Medicine in Global Market
Table 5. Top OTC Anti-Infective Medicine Players in Global Market, Ranking by Revenue (2024)
Table 6. Global OTC Anti-Infective Medicine Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global OTC Anti-Infective Medicine Revenue Share by Companies, 2020-2025
Table 8. Global Companies OTC Anti-Infective Medicine Product Type
Table 9. List of Global Tier 1 OTC Anti-Infective Medicine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 OTC Anti-Infective Medicine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global OTC Anti-Infective Medicine Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global OTC Anti-Infective Medicine Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America OTC Anti-Infective Medicine Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe OTC Anti-Infective Medicine Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia OTC Anti-Infective Medicine Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America OTC Anti-Infective Medicine Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa OTC Anti-Infective Medicine Revenue, (US$, Mn), 2026-2032
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline OTC Anti-Infective Medicine Product Offerings
Table 32. GlaxoSmithKline OTC Anti-Infective Medicine Revenue (US$, Mn) & (2020-2025)
Table 33. GlaxoSmithKline Key News & Latest Developments
Table 34. Merck Corporate Summary
Table 35. Merck OTC Anti-Infective Medicine Product Offerings
Table 36. Merck OTC Anti-Infective Medicine Revenue (US$, Mn) & (2020-2025)
Table 37. Merck Key News & Latest Developments
Table 38. Pfizer Corporate Summary
Table 39. Pfizer OTC Anti-Infective Medicine Product Offerings
Table 40. Pfizer OTC Anti-Infective Medicine Revenue (US$, Mn) & (2020-2025)
Table 41. Pfizer Key News & Latest Developments
Table 42. Novartis Corporate Summary
Table 43. Novartis OTC Anti-Infective Medicine Product Offerings
Table 44. Novartis OTC Anti-Infective Medicine Revenue (US$, Mn) & (2020-2025)
Table 45. Novartis Key News & Latest Developments
Table 46. Abbott Corporate Summary
Table 47. Abbott OTC Anti-Infective Medicine Product Offerings
Table 48. Abbott OTC Anti-Infective Medicine Revenue (US$, Mn) & (2020-2025)
Table 49. Abbott Key News & Latest Developments
Table 50. Sanofi Corporate Summary
Table 51. Sanofi OTC Anti-Infective Medicine Product Offerings
Table 52. Sanofi OTC Anti-Infective Medicine Revenue (US$, Mn) & (2020-2025)
Table 53. Sanofi Key News & Latest Developments
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb OTC Anti-Infective Medicine Product Offerings
Table 56. Bristol-Myers Squibb OTC Anti-Infective Medicine Revenue (US$, Mn) & (2020-2025)
Table 57. Bristol-Myers Squibb Key News & Latest Developments
Table 58. Roche Corporate Summary
Table 59. Roche OTC Anti-Infective Medicine Product Offerings
Table 60. Roche OTC Anti-Infective Medicine Revenue (US$, Mn) & (2020-2025)
Table 61. Roche Key News & Latest Developments


List of Figures
Figure 1. OTC Anti-Infective Medicine Product Picture
Figure 2. OTC Anti-Infective Medicine Segment by Type in 2024
Figure 3. OTC Anti-Infective Medicine Segment by Application in 2024
Figure 4. Global OTC Anti-Infective Medicine Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global OTC Anti-Infective Medicine Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global OTC Anti-Infective Medicine Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by OTC Anti-Infective Medicine Revenue in 2024
Figure 9. Segmentation by Type � Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global OTC Anti-Infective Medicine Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
Figure 13. By Region - Global OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
Figure 14. By Country - North America OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
Figure 15. United States OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 16. Canada OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
Figure 19. Germany OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 20. France OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 22. Italy OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 23. Russia OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
Figure 27. China OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 28. Japan OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 31. India OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
Figure 33. Brazil OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa OTC Anti-Infective Medicine Revenue Market Share, 2020-2032
Figure 36. Turkey OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 37. Israel OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 39. UAE OTC Anti-Infective Medicine Revenue, (US$, Mn), 2020-2032
Figure 40. GlaxoSmithKline OTC Anti-Infective Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Merck OTC Anti-Infective Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Pfizer OTC Anti-Infective Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Novartis OTC Anti-Infective Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Abbott OTC Anti-Infective Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Sanofi OTC Anti-Infective Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Bristol-Myers Squibb OTC Anti-Infective Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Roche OTC Anti-Infective Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About OTC Anti-Infective Medicine and Forecast Market

Leave This Empty: